Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axonics Inc (NQ: AXNX )

66.67 +0.20 (+0.30%)
Streaming Delayed Price Updated: 12:45 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axonics Inc

< Previous 1 2 3 4 Next >
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major... 
Via Benzinga
Exposures Product Safety
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
Via Benzinga
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. 
Via Benzinga
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
Analyst Scoreboard: 5 Ratings For Axonics
Via Benzinga
Why Axonics Stock Soared Today
The medical device maker agreed to be acquired by Boston Scientific. 
Via The Motley Fool
Health Care Company Boston Scientific Announces Acquisition of Axonics
Via Benzinga
Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
10 Top Stocks With a Strong Buy Rating Right Now
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. 
Via InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
Peeling Back The Layers: Exploring Axonics Through Analyst Insights
Via Benzinga
Earnings Outlook For Axonics
Via Benzinga
Why Is Crocs (CROX) Stock Up 20% Today?
Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024! 
Via InvestorPlace
Why Is Axonics (AXNX) Stock Up 20% Today?
Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific. 
Via InvestorPlace
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7 
Via Benzinga
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
The year's biggest medical conference kicked off with a melee of buyout news. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Analyst Ratings for Axonics
Via Benzinga
Why Shares of Axonics Rose Friday
The company showed improved revenue and margins in its second-quarter report. 
Via The Motley Fool
Earnings Outlook For Axonics
Via Benzinga
The Latest Analyst Ratings for Axonics
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Where Axonics Stands With Analysts
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Axonics Positioned For Rapid Penetration In Underserved Market, Analyst Initiates With Bullish Tone
KeyBanc Capital markets initiated coverage on Axonics Inc (NASDAQ: AXNX) with an Overweight rating and a  
Via Benzinga
Analyst Ratings for Axonics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Axonics Q1 Soars Past Estimates: Analysts Say Annual Sales Outlook Is 'Conservative'
Axonics Inc (NASDAQ: AXNX) reported a Q1 EPS loss of $(0.19), better than the consensus of $(0.29). 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.